These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29599203)

  • 1. Successful treatment of disseminated Rosai-Dorfman disease with siltuximab.
    Lee H; King G; Garg K; Pan Z; Tobin J; Robinson WA
    Haematologica; 2018 Jul; 103(7):e325-e328. PubMed ID: 29599203
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of intracranial Rosai-Dorfman disease with cytarabine and dexamethasone: case report and review of literature.
    Wang W; Sun J; Zhang W; Zhou D
    Ann Hematol; 2020 May; 99(5):1157-1159. PubMed ID: 32236734
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab].
    Petschner F; Walker UA; Schmitt-Gräff A; Uhl M; Peter HH
    Dtsch Med Wochenschr; 2001 Sep; 126(37):998-1001. PubMed ID: 11555773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosai-Dorfman disease of the colon.
    Nathwani RA; Kenyon L; Kowalski T
    Gastrointest Endosc; 2008 Jul; 68(1):194-6. PubMed ID: 18291397
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy.
    Gebhardt C; Averbeck M; Paasch U; Ugurel S; Kurzen H; Stumpp P; Simon JC; Treudler R
    Arch Dermatol; 2009 May; 145(5):571-4. PubMed ID: 19451502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with cladribine in a patient with Rosai-Dorfman disease complicated by severe, prolonged marrow aplasia.
    Robak T; Braun M; Guminska A; Iskierka-Jażdżewska E; Robak P
    Leuk Lymphoma; 2024 Aug; 65(8):1175-1180. PubMed ID: 38608253
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary manifestations revealing Rosai-Dorfman disease.
    Goupil de Bouillé J; de Muret A; Diot E; Dumont P; Plantier L; Diot P; Marchand-Adam S
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):275-7. PubMed ID: 26422575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended treatment response to imatinib in Rosai-Dorfman disease.
    Singh A; Simons Y; Biren-Fetz J; Mohapatra G; Ni H; Gaitonde S; Khan I
    Eur J Haematol; 2021 Jun; 106(6):868-870. PubMed ID: 33619765
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosai-Dorfman disease presenting in the oropharynx.
    Silver AL; Farkash EA; Pitman MB; Rocco JW
    Head Neck; 2011 Nov; 33(11):1660-3. PubMed ID: 20544818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery.
    Saboo SS; Jagannathan JP; Krajewski KM; O'Regan K; Hornick JL; Fisher DC; Ramaiya N
    J Clin Oncol; 2011 Nov; 29(31):e772-5. PubMed ID: 21931038
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosai-Dorfman disease with extranodal involvement.
    Hashimoto K; Kariya S; Onoda T; Ooue T; Yamashita Y; Naka K; Okano M; Nishizaki K
    Laryngoscope; 2014 Mar; 124(3):701-4. PubMed ID: 23818241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT; Houghton K; Bond M; Senger C; Tucker LB
    J Rheumatol; 2010 Aug; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract]   [Full Text] [Related]  

  • 14. A Rare Case of Multiorgan Involvement of Rosai Dorfman Disease in an Elderly Female.
    Waghmare RD
    JNMA J Nepal Med Assoc; 2014; 52(195):955-7. PubMed ID: 26982675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosai-Dorfman Disease with Systemic Multiple Involvement: A Case Report.
    Yu J; Tang B; Shi Y; Zou P; Zhang G; Ding Y; Xiao R
    Acta Derm Venereol; 2019 Dec; 99(13):1305-1306. PubMed ID: 31612238
    [No Abstract]   [Full Text] [Related]  

  • 16. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): imaging manifestations in the head and neck.
    La Barge DV; Salzman KL; Harnsberger HR; Ginsberg LE; Hamilton BE; Wiggins RH; Hudgins PA
    AJR Am J Roentgenol; 2008 Dec; 191(6):W299-306. PubMed ID: 19020219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary lymphohistiocytic tumour of bone: a primary osseous localization of Rosai-Dorfman disease.
    Allegranza A; Barbareschi M; Solero CL; Fornari M; Lasio G
    Histopathology; 1991 Jan; 18(1):83-6. PubMed ID: 2013464
    [No Abstract]   [Full Text] [Related]  

  • 18. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.
    Karadag AS; Tekin B; Hurdogan O; Dagdelen D; Dogan O; Buyukbabani N
    Dermatol Ther; 2019 Jan; 32(1):e12759. PubMed ID: 30288863
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosai-Dorfman disease with extranodal manifestation in the head.
    Sennes L; Koishi H; Cahali R; Sperandio F; Butugan O
    Ear Nose Throat J; 2004 Dec; 83(12):844-7. PubMed ID: 15724744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial Rosai-Dorfman disease with unusual transcranial extension.
    Lu CH; Chang KC; Lee EJ; Chuang MT; Chang RS
    J Neuroimaging; 2012 Jul; 22(3):312-5. PubMed ID: 21091818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.